Stay updated on Pembrolizumab in 1st Line NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in 1st Line NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, indicating a minor version update for the page. No substantive content or data changes are reflected in this change set.
    Difference
    0.0%
    Check dated 2026-06-05T11:42:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new publication citation has been added in Publications for the KEYNOTE-189 Japan extension study, with authors and journal details; the entry also indicates a version revision from v3.5.3 to v3.5.4.
    Difference
    0.1%
    Check dated 2026-05-14T23:18:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows an updated revision label 'Revision: v3.5.3' replacing the previous 'Revision: v3.5.2', indicating a software release rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-04-30T16:27:23.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-16T09:34:09.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T15:39:06.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, replacing the previous v3.4.2. This is a minor UI/version update and does not change study details or user interactions on the page.
    Difference
    0.0%
    Check dated 2026-03-11T14:42:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in 1st Line NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in 1st Line NSCLC Clinical Trial page.